Mary-Elizabeth (Muchmore) Percival, MD, Oncology, Seattle, WA, University of Washington Medical Center

Mary-ElizabethMuchmore(Muchmore)PercivalMD

Oncology Seattle, WA

Hematologic Oncology

Physician

Dr. Percival is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Percival's full profile

Already have an account?

Education & Training

  • Stanford University
    Stanford UniversityFellowship, Hematology, 2011 - 2014
  • UCSF
    UCSFResidency, Internal Medicine, 2007 - 2010
  • Stanford University School of Medicine
    Stanford University School of MedicineClass of 2007

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2015 - 2022
  • CA State Medical License
    CA State Medical License 2009 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast Count
    Mary-Elizabeth M. Percival, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia
    Mary-Elizabeth M. Percival, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Mini- Vs. Regular-Dose CLAG-M (Cladribine, Cytarabine, G-CSF, and Mitoxantrone) in Medically Less Fit Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and Othe...
    Mary-Elizabeth M. Percival, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Frequency, and Effect on Survival, of Ineligibility for Clinical Trials in Newly Diagnosed Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Impact of Depth of Pretransplant Clinical Response on Outcomes of Acute Myeloid Leukemia Patients in First Complete Remission (AML-CR1) Who Undergo Allogeneic Hematopo... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Limitations to Receiving Allogeneic Hematopoietic Cell Transplantation for Treatment of Acute Myeloid Leukemia: A Large Multi-Center Prospective Longitudinal Observati... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Hospital Affiliations